Have a feature idea you'd love to see implemented?
Let us know!
STAA Staar Surgical Co
Price (delayed)
$30.19
Market cap
$1.48B
P/E Ratio
88.79
Dividend/share
N/A
EPS
$0.34
Enterprise value
$1.33B
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are
Highlights
STAA's P/E is 53% below its 5-year quarterly average of 191.7 and 16% below its last 4 quarters average of 106.0
Staar Surgical's equity has increased by 16% YoY and by 4.2% QoQ
Staar Surgical's EPS has decreased by 37% YoY but it has increased by 6% QoQ
Staar Surgical's net income has decreased by 36% YoY but it has increased by 9% from the previous quarter
Staar Surgical's debt has increased by 12% YoY
STAA's quick ratio is down by 6% YoY
Key stats
What are the main financial stats of STAA
Market
Valuations
Earnings
Shares outstanding
49.19M
Market cap
$1.48B
Enterprise value
$1.33B
Price to earnings (P/E)
88.79
Price to book (P/B)
3.63
Price to sales (P/S)
4.45
EV/EBIT
61.44
EV/EBITDA
49.32
EV/Sales
3.99
Revenue
$332.94M
EBIT
$21.62M
EBITDA
$26.94M
Free cash flow
$13.55M
Per share
Balance sheet
Liquidity
EPS
$0.34
Free cash flow per share
$0.28
Book value per share
$8.33
Revenue per share
$6.78
TBVPS
$10.4
Total assets
$512.75M
Total liabilities
$103.64M
Debt
$36.27M
Equity
$409.1M
Working capital
$317.65M
Debt to equity
0.09
Current ratio
5.8
Quick ratio
4.97
Net debt/EBITDA
-5.81
Margins
Efficiency
Dividend
EBITDA margin
8.1%
Gross margin
79.2%
Net margin
5%
Operating margin
7.9%
Return on assets
3.4%
Return on equity
4.2%
Return on invested capital
7.7%
Return on capital employed
4.8%
Return on sales
6.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STAA stock price
How has the Staar Surgical stock price performed over time
Intraday
-0.76%
1 week
-5.83%
1 month
-0.56%
1 year
-27.34%
YTD
-3.27%
QTD
-18.73%
Financial performance
How have Staar Surgical's revenue and profit performed over time
Revenue
$332.94M
Gross profit
$263.81M
Operating income
$26.32M
Net income
$16.61M
Gross margin
79.2%
Net margin
5%
Staar Surgical's net margin has decreased by 40% YoY but it has increased by 6% from the previous quarter
Staar Surgical's net income has decreased by 36% YoY but it has increased by 9% from the previous quarter
STAA's operating income is up by 14% since the previous quarter
Staar Surgical's operating margin has increased by 11% from the previous quarter but it has decreased by 7% YoY
Growth
What is Staar Surgical's growth rate over time
Valuation
What is Staar Surgical stock price valuation
P/E
88.79
P/B
3.63
P/S
4.45
EV/EBIT
61.44
EV/EBITDA
49.32
EV/Sales
3.99
STAA's P/E is 53% below its 5-year quarterly average of 191.7 and 16% below its last 4 quarters average of 106.0
Staar Surgical's EPS has decreased by 37% YoY but it has increased by 6% QoQ
STAA's price to book (P/B) is 71% lower than its 5-year quarterly average of 12.5 and 26% lower than its last 4 quarters average of 4.9
Staar Surgical's equity has increased by 16% YoY and by 4.2% QoQ
The stock's price to sales (P/S) is 69% less than its 5-year quarterly average of 14.5 and 24% less than its last 4 quarters average of 5.9
The revenue has grown by 9% YoY and by 2.1% from the previous quarter
Efficiency
How efficient is Staar Surgical business performance
Staar Surgical's return on assets has decreased by 45% YoY but it has increased by 6% QoQ
The ROE has contracted by 45% YoY but it has grown by 5% from the previous quarter
Staar Surgical's return on sales has decreased by 32% YoY but it has increased by 7% QoQ
The ROIC has decreased by 21% YoY but it has increased by 13% from the previous quarter
Dividends
What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STAA.
Financial health
How did Staar Surgical financials performed over time
Staar Surgical's total liabilities has increased by 19% YoY and by 3.9% from the previous quarter
The total assets is up by 16% year-on-year and by 4.1% since the previous quarter
Staar Surgical's debt is 91% less than its equity
Staar Surgical's equity has increased by 16% YoY and by 4.2% QoQ
Staar Surgical's debt has increased by 12% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.